Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) EPS (Basic): 2016-2025

Historic EPS (Basic) for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $1.

  • Collegium Pharmaceutical's EPS (Basic) rose 244.83% to $1 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.85, marking a year-over-year decrease of 32.48%. This contributed to the annual value of $2.14 for FY2024, which is 49.65% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its EPS (Basic) stood at $1 for Q3 2025, which was up 163.16% from $0.38 recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's EPS (Basic) registered a high of $2.06 during Q2 2021, and its lowest value of -$0.73 during Q4 2021.
  • Over the past 3 years, Collegium Pharmaceutical's median EPS (Basic) value was $0.39 (recorded in 2024), while the average stood at $0.46.
  • In the last 5 years, Collegium Pharmaceutical's EPS (Basic) crashed by 465.00% in 2021 and then spiked by 6,000.00% in 2023.
  • Collegium Pharmaceutical's EPS (Basic) (Quarterly) stood at -$0.73 in 2021, then surged by 71.23% to -$0.21 in 2022, then skyrocketed by 571.43% to $0.99 in 2023, then tumbled by 60.61% to $0.39 in 2024, then spiked by 244.83% to $1 in 2025.
  • Its EPS (Basic) stands at $1 for Q3 2025, versus $0.38 for Q2 2025 and $0.08 for Q1 2025.